Mark Hasleton

Mark Hasleton

Vorstandsvorsitzender bei
ProTA Therapeutics Pty Ltd.
54 Jahre
Health Technology
Consumer Services

Profil

Mark Hasleton currently works at Prota Therapeutics Pty Ltd., as Chief Executive Officer.
Dr. Hasleton also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Director-Global New Therapeutic Entities from 2010 to 2018, Bristol Myers Squibb Co., as Manager-EMEA Business Operations, and Oramed Pharmaceuticals, Inc., as Vice President-Business Development from 2018 to 2019.
Dr. Hasleton received his doctorate degree from Imperial College London, graduate degree from The University of Manchester, and Masters Business Admin degree from Imperial College Business School.

Aktive Positionen von Mark Hasleton

UnternehmenPositionBeginn
Vorstandsvorsitzender -

Ehemalige bekannte Positionen von Mark Hasleton

UnternehmenPositionEnde
ORAMED PHARMACEUTICALS INC. Corporate Officer/Principal 27.08.2019
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01.01.2018
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Mark Hasleton im Detail an

Ausbildung von Mark Hasleton

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

77

Beziehungen ersten Grades

7

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Börse
  2. Insiders
  3. Mark Hasleton